AVROBIO enters into definitive merger with Tectonic Therapeutic

Tectonic Therapeutic, Inc.

AVRO (AVRO) signs merger agreement with Tectonic; Merger Sub will merge into Tectonic, making it a wholly-owned subsidiary.
Deal announced January 30, 2024; combined company to focus on discovery of novel GPCR-targeted therapies.
Investor webcast and slide presentation available on AVRO's website; closing subject to customary conditions and approvals.
Specific financial terms (deal value, premium, expected close date) not stated in the provided exhibit text.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.